# Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients

> **NCT02042612** · PHASE2 · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 8 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Sedation with sevoflurane during 48-hr in ICU

## Key facts

- **NCT ID:** NCT02042612
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-01
- **Final completion:** 2015-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02042612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02042612, "Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT02042612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*